microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2.

Du L, Billaud JN, Telwatte S, Kadiyala N, Dabral P, Bouzidi MS, Guatelli J, Yukl SA, Pillai SK

Open source

DOI
10.1016/j.omtn.2026.102844
Published
2026 Mar 12
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2026.102844,
  title = {microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2.},
  author = {Du L and Billaud JN and Telwatte S and Kadiyala N and Dabral P and Bouzidi MS and Guatelli J and Yukl SA and Pillai SK},
  year = {2026},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2026.102844},
  url = {https://doi.org/10.1016/j.omtn.2026.102844}
}

RIS

TY  - JOUR
TI  - microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2.
AU  - Du L
AU  - Billaud JN
AU  - Telwatte S
AU  - Kadiyala N
AU  - Dabral P
AU  - Bouzidi MS
AU  - Guatelli J
AU  - Yukl SA
AU  - Pillai SK
PY  - 2026
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2026.102844
UR  - https://doi.org/10.1016/j.omtn.2026.102844
ER  - 

APA

L, D., JN, B., S, T., N, K., P, D., MS, B., J, G., SA, Y., & SK, P. (2026). microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2026.102844

Source records